Cargando…
Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476095/ https://www.ncbi.nlm.nih.gov/pubmed/37671286 http://dx.doi.org/10.3389/fpsyt.2023.1266566 |
| _version_ | 1785100852849016832 |
|---|---|
| author | Falkai, Peter Dombi, Zsófia Borbála |
| author_facet | Falkai, Peter Dombi, Zsófia Borbála |
| author_sort | Falkai, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10476095 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104760952023-09-05 Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II Falkai, Peter Dombi, Zsófia Borbála Front Psychiatry Psychiatry Frontiers Media S.A. 2023-08-21 /pmc/articles/PMC10476095/ /pubmed/37671286 http://dx.doi.org/10.3389/fpsyt.2023.1266566 Text en Copyright © 2023 Falkai and Dombi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Psychiatry Falkai, Peter Dombi, Zsófia Borbála Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II |
| title | Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II |
| title_full | Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II |
| title_fullStr | Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II |
| title_full_unstemmed | Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II |
| title_short | Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II |
| title_sort | editorial: community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with d3-d2 partial agonists, volume ii |
| topic | Psychiatry |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476095/ https://www.ncbi.nlm.nih.gov/pubmed/37671286 http://dx.doi.org/10.3389/fpsyt.2023.1266566 |
| work_keys_str_mv | AT falkaipeter editorialcommunityseriesinnovelantipsychoticswithinandbeyondclinicaltrialssymptombasedtreatmentofpsychiatricdisorderswithd3d2partialagonistsvolumeii AT dombizsofiaborbala editorialcommunityseriesinnovelantipsychoticswithinandbeyondclinicaltrialssymptombasedtreatmentofpsychiatricdisorderswithd3d2partialagonistsvolumeii |